Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia: Results from the Real-World Outcomes Collaborative of Chimeric Antigen Receptor T in Adult Acute Lymphoblastic Leukemia.
Journal: Transplantation and cellular therapy
Published: April 21, 2026
Zamtocabtagene autoleucel: dual CD20-CD19 targeting for NHL.
Journal: Blood advances
Published: April 02, 2026
Superior Chronic Graft-versus-Host Disease-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: November 18, 2025
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene.
Journal: Blood
Published: September 19, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.
Journal: Cancer discovery
Published: July 26, 2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.
Journal: Transplantation and cellular therapy
Published: January 29, 2024
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study.
Journal: Lancet (London, England)
Published: November 29, 2023
Last Updated: 09/26/2026